These data are in line with previously published work showing single agent activity of CHK inhibitors in MYC driven lymphoma mouse models which recapitulate human Burkitt lymphoma [16], suggesting that Burkitt lymphoma and DLBCL share dysregulation of the DDR as a common pathogenetic feature. Here, MYC is linked to Burkitt lymphoma.